Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H. Therapeutics and Clinical Risk
The Editor-in-Chief and Publisher of Therapeutics and Clinical Risk Management wish
to issue an Expression of concern for the above published article.
The Journal Editors received notification from an investigator raising concerns about
the published paper. These concerns relate to the high similarity in content to the
article ‘Experience with alendronate treatment for 7 years among Japanese men with
osteoporosis or osteopenia and clinical risk factors for fractures’. Iwamoto J, Uzawa
M. Clinical Rheumatology. 2016;35:205–212. There were also concerns raised relating
to the timeline for study conduct and manuscript preparation. The article reports
the study took place between July 1st and September 30th, 2010 and was submitted for
publication on Oct 24, 2010.
Dove Medical Press attempted to contact the authors of the article and their affiliated
institution regarding these concerns but received no response. As we were unable to
make a definitive conclusion, we would like to alert readers to these issues and allow
them to draw their own conclusions. This decision follows the recommendations of the
Committee on Publication Ethics (COPE).
The Editor and Dove Medical Press make every effort to ensure publication ethics are
upheld and are committed to supporting the high standards of the Therapeutics and
Clinical Risk Management journal.